At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 24 enrolled
Drug / intervention
1% diclofenac sodium gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Within-Subject, Proof of Concept Study to Assess the Analgesic Efficacy and Safety of Voltaren Gel (1% Diclofenac Sodium) Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness
In Brief
A Phase 4 clinical trial evaluating 1% diclofenac sodium gel and Placebo for Pain and Delayed Onset Muscle Soreness. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate analgesic efficacy of Topical Voltaren Gel (diclofenac sodium gel) 1% applied QID compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Delayed Onset Muscle Soreness
CountriesUnited States
CollaboratorsNovartis Pharmaceuticals
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
First PostedMar 2014
Primary CompletionApr 2014
Study CompletionMay 2014
TodayJul 2026
First PostedMar 14, 2014
Enrollment StartMar 1, 2014
Primary CompletionApr 1, 2014
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 12.3 years ago
Interventions
1% diclofenac sodium geldrug
Diclofenac sodium 1% gel 4 grams applied topically Q6 hour for 48 hours
Placebodrug
Placebo gel 4gm applied topically Q6 hour for 48 hours